Varaico: Literature-Extracted Genetic Variants

Gene:NCF1
Variant:p.W193*
Back to variants list

NCF1

NM_000265.7:p.W193*

Associated Papers

Adult genomic medicine: lessons from a multisite study of 2700 patients.

Bakur K et al.

Genome Medicine, 2025

41024252 (PubMed )
Supplement: 13073_2025_1529_MOESM1_ESM.xlsx › Sheet1

Genome-wide profiling of highly similar paralogous genes using HiFi sequencing.

Chen X et al.

Nature Communications, 2025

40057485 (PubMed )
Supplement: 41467_2025_57505_MOESM3_ESM.xlsx › Supplementary_Data_2

Reliable genetic diagnosis of NCF1 (p47phox)-deficient chronic granulomatous disease using high-throughput sequencing.

Hsu AP et al.

Frontiers in Immunology, 2025

Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohort.

Wolach B et al.

Blood, 2024

Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature Review.

Micheloni G et al.

Genes, 2023

Comprehensive Genetic Analysis of Druze Provides Insights into Carrier Screening.

Avnat E et al.

Genes, 2023

Genetic Causes, Clinical Features, and Survival of Underlying Inborn Errors of Immunity in Omani Patients: a Single-Center Study.

Al-Tamemi S et al.

Journal of Clinical Immunology, 2023

Chronic granulomatous disease in the United Arab Emirates: clinical and molecular characteristics in a single center.

Al Kuwaiti AA et al.

Frontiers in Immunology, 2023

Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.

Akar HT et al.

Journal of Clinical Immunology, 2021

Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.

Bakri FG et al.

Frontiers in Immunology, 2021

Late diagnosis of chronic granulomatous disease.

Barkai T et al.

Clinical and Experimental Immunology, 2020

2020 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference.

Unknown Author

Journal of Clinical Immunology, 2020

Reinterpretation of common pathogenic variants in ClinVar revealed a high proportion of downgrades.

Xiang J et al.

Scientific Reports, 2020

31942019 (PubMed )
Supplement: 41598_2019_57335_MOESM1_ESM.xlsx › Sup_table_1

The Israeli national population program of genetic carrier screening for reproductive purposes. How should it be continued?

Zlotogora J

Israel Journal of Health Policy Research, 2019

Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes.

Capalbo A et al.

Plos Genetics, 2019

31589614 (PubMed )
Supplement: pgen.1008409.s001.xlsx › P_LP_Variants

NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis.

Kuhns DB et al.

Blood Advances, 2019

High-frequency actionable pathogenic exome variants in an average-risk cohort.

Rego S et al.

Cold Spring Harbor Molecular Case Studies, 2018

30487145 (PubMed )
Supplement: supp_mcs.a003178_Supplemental_File_1.xlsx › Sheet1

Correlation between flow cytometry and molecular findings in autosomal recessive chronic granulomatous disease: A cohort study from Oman.

Al-Riyami AZ et al.

International Journal of Laboratory Hematology, 2018

Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.

Denson LA et al.

Gastroenterology, 2018

A false-carrier state for the c.579G>A mutation in the NCF1 gene in Ashkenazi Jews.

De Boer M et al.

Journal of Medical Genetics, 2018

Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).

Wolach B et al.

Journal of Clinical Immunology, 2018

A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.

Ben-Farhat K et al.

Journal of Clinical Immunology, 2016

Expanding preconception carrier screening for the Jewish population using high throughput microfluidics technology and next generation sequencing.

Gal M et al.

Bmc Medical Genomics, 2016

27175728 (PubMed )
Supplement: 12920_2016_184_MOESM1_ESM.xls › S1

A founder effect for p47(phox)Trp193Ter chronic granulomatous disease in Kavkazi Jews.

de Boer M et al.

Blood Cells, Molecules & Diseases, 2015

Clinical application of whole-genome sequencing in patients with primary immunodeficiency.

Mousallem T et al.

The Journal of Allergy and Clinical Immunology, 2015

Clinical and molecular findings of chronic granulomatous disease in Oman: family studies.

Al-Zadjali S et al.

Clinical Genetics, 2015

Integrated analysis of germline and somatic variants in ovarian cancer.

Kanchi KL et al.

Nature Communications, 2014

24448499 (PubMed )
Supplement: NIHMS551112-supplement-12.xlsx › S_Data_11

Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).

Roos D et al.

Blood Cells, Molecules & Diseases, 2010

Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease.

Freudenberg F et al.

The Journal of Allergy and Clinical Immunology, 2010

Mutations of chronic granulomatous disease in Turkish families.

Köker MY et al.

European Journal of Clinical Investigation, 2007

Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase.

Roos D et al.

Human Mutation, 2006

Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?

Zlotogora J et al.

The Israel Medical Association Journal : Imaj, 2000

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."